These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7933783)

  • 21. [Clinical contribution to the study of indobufen, a new platelet aggregation inhibitor].
    Ciammaichella A; Luzi M; Pezzi F; Recchia O
    Clin Ter; 1982 Aug; 102(4):387-95. PubMed ID: 6754219
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of ticlopidine and indobufen on platelet aggregation induced by A23187 and adrenaline in the presence of different anticoagulants.
    Cimminiello C; Milani M; Uberti T; Arpaia G; Bonfardeci G
    J Int Med Res; 1989; 17(6):514-20. PubMed ID: 2516825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of indobufen on platelet thromboxane B2 production in patients with myocardial infarction.
    Rebuzzi AG; Natale A; Bianchi C; Mariello F; Coppola E; Ciabattoni G
    Eur J Clin Pharmacol; 1990; 39(1):99-100. PubMed ID: 2276396
    [No Abstract]   [Full Text] [Related]  

  • 24. Study on the platelet factor and beta-thromboglobulin in the patients with ischemic heart disease.
    Kim MH; Huo SH; Kim KS; Kim MS; Song JS
    Korean J Intern Med; 1986 Jan; 1(1):1-6. PubMed ID: 15759368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of aspirin and indobufen in healthy volunteers.
    Lee JY; Sung KC; Choi HI
    Platelets; 2016; 27(2):105-9. PubMed ID: 26083594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antithrombotic therapy in acute coronary syndrome].
    Chazov EI; Panchenko EP
    Ter Arkh; 2000; 72(3):65-75. PubMed ID: 10776658
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of indobufen and pentoxifylline on walking capacity and hemostasis in patients with intermittent claudication: results of six months of treatment.
    Panchenko E; Eshkeeva A; Dobrovolsky A; Titaeva E; Podinovskaya Ya; Hussain KM; Karpov Yu
    Angiology; 1997 Mar; 48(3):247-54. PubMed ID: 9071201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinico-hematological evaluation of 57 patients undergoing antiaggregant treatment with indobufen].
    Andriani A; Mosiello G; Chiappetta MG; Gregori G; Rinaldi P
    Recenti Prog Med; 1990 Jan; 81(1):49-53. PubMed ID: 2236828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High post-treatment platelet reactivity is associated with a high incidence of myonecrosis after stenting for non-ST elevation acute coronary syndromes.
    Cuisset T; Frere C; Quilici J; Morange PE; Nait-Saidi L; Mielot C; Bali L; Lambert M; Alessi MC; Bonnet JL
    Thromb Haemost; 2007 Feb; 97(2):282-7. PubMed ID: 17264958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indobufen versus placebo in the prevention of restenosis after carotid endarterectomy: a double-blind pilot study.
    Pratesi C; Pulli R; Milanesi G; Lavezzari M; Pamparana F; Bertini D
    J Int Med Res; 1991; 19(3):202-9. PubMed ID: 1936509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different patterns of inhibition of adrenaline-induced platelet aggregation and kinetics in vivo by acetylsalicylic acid and indobufen.
    Fortunato JS; Pinheiro MJ; Monteiro MC; Rodrigues MA; Amaral I
    J Int Med Res; 1991; 19(4):305-17. PubMed ID: 1916004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet aggregation and aspirin non-responsiveness increase when an acute coronary syndrome is complicated by an infection.
    Modica A; Karlsson F; Mooe T
    J Thromb Haemost; 2007 Mar; 5(3):507-11. PubMed ID: 17319905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Platelet aggregation inhibitory therapy in chronic arterial occlusive disease of the lower limbs: results of short-term clinico-instrumental study with indobufen].
    Landini G; Poggiali C; Calacoci S; Marino N; Rosselli A
    Recenti Prog Med; 1989 Apr; 80(4):204-7. PubMed ID: 2762658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between paraoxonase-1 activity, its Q192R genetic variant and clopidogrel responsiveness in the ADRIE study.
    Fontana P; James R; Barazer I; Berdagué P; Schved JF; Rebsamen M; Vuilleumier N; Reny JL
    J Thromb Haemost; 2011 Aug; 9(8):1664-6. PubMed ID: 21692977
    [No Abstract]   [Full Text] [Related]  

  • 35. Indobufen versus dipyridamole plus aspirin in the treatment of patients with peripheral atherosclerotic disease.
    Fabris F; Steffan A; Randi ML; Avruscio GP; Cordiano I; Girolami A
    J Med; 1992; 23(2):81-92. PubMed ID: 1512524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid peroxidation products and changes in phospholipid composition induced by indobufen in diabetic platelets.
    Dmoszyńska A; Walter-Croneck A; Ledwozyw A
    Thromb Res; 1995 Sep; 79(5-6):483-90. PubMed ID: 7502274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antiaggregating effect of indobufen. Preliminary results of a study of 20 patients].
    Andriani A; Chiappetta MG; Mannarino E; Mosiello G; Zampa G; Beni A
    Recenti Prog Med; 1986 Dec; 77(12):580-6. PubMed ID: 3563087
    [No Abstract]   [Full Text] [Related]  

  • 38. [Italian Study on Atrial Fibrillation (SIFA): status report].
    Amabile G; Matteoli S; Fattapposta F; Lavezzari M; Trappolini M; Heiman F; Morocutti C
    Cardiologia; 1993 Dec; 38(12 Suppl 1):327-32. PubMed ID: 8020032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of treatment with indobufen on blood viscosity indices and exercise tolerance in patients with coronary disease].
    Rdzanek H; Kochmański M; Zochowski RJ
    Wiad Lek; 1993 Apr; 46(7-8):245-9. PubMed ID: 8249409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diltiazem inhibits the spontaneous platelet aggregation in essential hypertension.
    Pechán J; Okrucká A
    Cardiology; 1991; 79(2):116-9. PubMed ID: 1834333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.